UNITED THERAPEUTICS Corp·4

Aug 5, 4:30 PM ET

DWEK RAYMOND 4

4 · UNITED THERAPEUTICS Corp · Filed Aug 5, 2024

Insider Transaction Report

Form 4
Period: 2024-08-02
DWEK RAYMOND
Director
Transactions
  • Sale

    Common Stock

    2024-08-02$320.39/sh900$288,3495,850 total
  • Exercise/Conversion

    Stock Options

    2024-08-025,00010,000 total
    Exercise: $175.43From: 2016-06-26Exp: 2025-06-26Common Stock (5,000 underlying)
  • Sale

    Common Stock

    2024-08-02$321.29/sh900$289,1584,950 total
  • Sale

    Common Stock

    2024-08-02$330.39/sh100$33,0391,750 total
  • Sale

    Common Stock

    2024-08-02$326.40/sh900$293,7574,050 total
  • Exercise/Conversion

    Common Stock

    2024-08-02$175.43/sh+5,000$877,1506,750 total
  • Sale

    Common Stock

    2024-08-02$327.95/sh1,300$426,3422,750 total
  • Sale

    Common Stock

    2024-08-02$328.99/sh900$296,0891,850 total
Footnotes (5)
  • [F1]This transaction was executed in multiple trades at prices ranging from $320.04 to $320.8924. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $321.14 to $321.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $325.98 to $326.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $327.505 to $328.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]This transaction was executed in multiple trades at prices ranging from $328.54 to $329.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    form4-08052024_040801.xmlPrimary